Skip to content
Catalyst

PapersPMID:38931273

Effects of Cocoa Consumption on Cardiometabolic Risk Markers: Meta-Analysis of Randomized Controlled Trials.

Nutrients2024The record ↗

findings
5
compound
1
endpoints
5
no difference found
1
PMID:38931273
  1. Finding, strong evidencelowersSystolic blood pressure
  2. Finding, strong evidencelowersDiastolic blood pressure
  3. Finding, moderate evidencelowersTotal cholesterol (TC)
  4. Finding, moderate evidencelowersLDL cholesterol
  5. Finding, moderate evidenceno difference foundGlycated haemoglobin (HbA1c)
Study, every finding
meta-analysis
Dose studied, every finding
daily cocoa intake 1.4 to 50.0 g across trials
  • “The overall analysis of the effect of cocoa consumption on blood pressure involved 22 studies (n = 1224) and showed a reduction in SBP of −2.52 mmHg (95% CI −4.17 to −0.88 mmHg) and a reduction in DBP of −1.58 mmHg (95% CI −2.54 to −0.62 mmHg).”
    • Participants
      1,224
      Effect
      −2.52 mean difference, 95% CI −4.17 to −0.88
      Population
      Adults aged 18 or over, healthy or with cardiometabolic risk factors; 22 pooled randomised trials of 4 weeks or longer
    • Participants
      1,224
      Effect
      −1.58 mean difference, 95% CI −2.54 to −0.62
      Population
      Adults aged 18 or over, healthy or with cardiometabolic risk factors; 22 pooled randomised trials of 4 weeks or longer
  • “Dietary cocoa consumption effectively reduced total cholesterol by −8.35 mg/dL (95% CI −14.01 to −2.69 mg/dL).”
    Effect
    −8.35 mean difference, 95% CI −14.01 to −2.69
    Population
    Adults aged 18 or over, healthy or with cardiometabolic risk factors; pooled randomised trials of 4 weeks or longer
  • “The analysis showed a reduction in LDL-c of −9.47 mg/dL (95% CI −13.75 to −5.20) with cocoa consumption.”
    Effect
    −9.47 mean difference, 95% CI −13.75 to −5.2
    Population
    Adults aged 18 or over, healthy or with cardiometabolic risk factors; pooled randomised trials of 4 weeks or longer, one outlier study excluded

What did not

  • “The other outcome of interest in glucose metabolism was HbA1c, and the results showed no effect of cocoa consumption on HbA1c.”
    Population
    Adults aged 18 or over, healthy or with cardiometabolic risk factors; pooled randomised trials of 4 weeks or longer, few studies

Study record

Design
meta-analysis
Species
human
Population
Adults aged 18 and over, healthy or with cardiometabolic risk factors, in 31 randomized trials of cocoa extract or dark chocolate of 70% cocoa or more
Participants
1,986
Comparator
placebo
Duration
84 days
Endpoints measured
20